324
Participants
Start Date
March 1, 2017
Primary Completion Date
August 13, 2021
Study Completion Date
August 13, 2021
Dapagliflozin 10Mg Oral Tablet
Dapagliflozin 10Mg Oral Tablet
Dapagliflozin matching placebo
Dapagliflozin matching placebo
Columbia University, New York
St. Francis Hospital, New York
Allegheny Health Network Research Institute, Pittsburgh
Johns Hopkins University, Baltimore
Eastern Virginia Medical School, Norfolk
Wake Forest University, Winston-Salem
Eastern Nephrology Associates, New Bern
Emory University, Atlanta
First Coast Cardiovascular Institute, Jacksonville
Charlotte Heart Group Research Center, Port Charlotte
Heart Group of the Eastern Shore, Fairhope
Vanderbilt University Medical Center, Nashville
St. Vincent Cardiovascular Research Institute, Indianapolis
Mayo Clinic, Rochester
NorthShore University HealthSystem Research Insititute, Evanston
Northwestern University, Evanston
Chicago Medical Research, Hazel Crest
OSF HealthCare Cardiovascular Institute, Peoria
Washington University, St Louis
Saint Luke's Mid America Heart Institute, Kansas City
Cotton O'Neil Clinical Research Center, Topeka
Baylor Scott and White Research Institute, Dallas
University of Utah, Salt Lake City
University of Southern California, Los Angeles
Oregon Health and Science University, Portland
Massachusetts Hospital, Boston
Saint Luke's Health System
OTHER